ANTHROPIC will open 10,000 Claude subscription slots to global scientists, offering one year of free or discounted access, and has partnered with the US government to provide MYTHOS-level model access for life sciences research.

ANTHROPIC is reportedly considering allowing existing shareholders to sell shares in its planned U.S. IPO, a departure from recent large-tech deals such as SpaceX that barred shareholder sales. Permitting secondary sales would let early investors, executives and employees realise part of their paper gains. The company plans to file its IPO prospectus after U.S. Labor Day (Sept. 7) and expects a mid-September investor day for potential investors and research analysts. The IPO could occur as early as late September or early October, but timing may change.

Fed's Hammack said contacts were very concerned about inflation and the cost of living.